Amplifier Health Partners with Xeomics

April 25, 2025 01:52 AM AEST | By EIN Presswire
 Amplifier Health Partners with Xeomics
Image source: EIN Presswire

To scale groundbreaking voice biomarker technology through accelerated data access

This collaboration exemplifies how strategic data access can swiftly advance diagnostic capabilities, ultimately improving patient outcomes on a global scale.”
— George Zarkadakis, CIO of Xeomics
NEW YORK, NY, UNITED STATES, April 24, 2025 /EINPresswire.com/ -- Amplifier Health, a pioneer in revolutionizing healthcare diagnostics through its advanced voice-based large acoustic models, today announced a strategic partnership with Xeomics, a global leader in precision medicine and healthcare data acceleration. This collaboration will fuel the refinement and scaling of Amplifier Health’s unique diagnostic capabilities by leveraging Xeomics' expertise in rapidly sourcing diverse, large-scale patient datasets.

To further train its revolutionary Large Acoustic Models – the world's first foundation model capable of detecting and monitoring a wide range of health conditions from the human voice – Amplifier Health has selected Xeomics for its proven ability to deliver accelerated access to rich, bespoke datasets. This access is critical for enhancing the platform's precision and expanding its diagnostic reach. Xeomics, through its extensive international network of healthcare partners, delivers accelerated access to diverse patient data, significantly shortening data acquisition timelines, enabling Amplifier Health to accelerate its research and development cycles.

Dr. Amit Mehta, MD, CEO of Amplifier Health, commented on the collaboration: "Our Large Acoustic Models represent a paradigm shift in non-invasive diagnostics, unlocking critical health insights hidden within the human voice. Partnering with Xeomics provides the crucial, high-quality data needed to rapidly refine and scale our technology, bringing the power of voice-based biomarkers to patients worldwide faster than ever before."

George Zarkadakis, Chief Innovation Officer of Xeomics, added: "Xeomics is dedicated to empowering healthcare innovators like Amplifier Health by accelerating the precision medicine journey. We are thrilled to support Amplifier Health's groundbreaking work in voice diagnostics by providing tailored data solutions through our global healthcare partnerships. This collaboration exemplifies how strategic data access can swiftly advance diagnostic capabilities, ultimately improving patient outcomes on a global scale."

Together, Amplifier Health and Xeomics aim to drive substantial advancements in diagnostic technology, fostering rapid innovation in precision medicine to benefit healthcare providers and patients worldwide.

About Amplifier Health

Amplifier Health is revolutionizing healthcare by extracting multiple biometrics and biomarkers from the human voice. With the world's first voice-based large acoustic model, Amplifier Health’s platform can detect and monitor a wide range of health conditions from speech. Accessing key data in the voice, Amplifier Health enables diagnosis and management in a frictionless manner making healthcare more accessible, affordable, and effective for everyone. For more information, visit www.amplifierhealth.com.

About Xeomics

Xeomics is a leading provider of innovative solutions and programs that focus on personalized medicine and population-wide healthcare. Xeomics collaborates with federal institutions, global organizations, and leading health systems in establishing community-wide and population-wide initiatives that enable precision medicine at scale. In support of these programs, Xeomics offers the Xeomics Precision Medicine Suite (XMPS), a best-in-class bioinformatics and precision medicine software solution that provides valuable healthcare insights and benefits to doctors and patients. For more information, visit www.xeomics.com.

For media inquiries or interview opportunities, please contact:

Hans Godfrey
Xeomics
[email protected]
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.